Assessment of Serum Levels of Phosphate and Corticosterone as Possible Biomarkers for Early Diagnosis of Parkinson’s Disease in Rats with ۶-OHDA-Induced Parkinson

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 102

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JKMU-31-3_001

تاریخ نمایه سازی: 27 مهر 1403

چکیده مقاله:

Background: Early diagnosis of Parkinson›s disease can play an important role in improving its prognosis. Due to controversies about the serum level of corticosterone and phosphate in parkinsonian rats, this study was designed to measure and evaluate the levels of corticosterone and phosphate as possible biomarkers of early diagnosis in rats with ۶-OHDA-induced parkinsonism.Methods: Forty rats were divided into three groups: control (n = ۱۰), sham (n = ۱۰), and ۶-OHDA (n = ۲۰). The rats in the ۶-OHDA and sham groups underwent stereotaxic surgery to be injected with ۶-OHDA and its carrier into their medial forebrain bundle (MFB). Apomorphine-induced rotational and cylinder tests were done to examine parkinsonism progression and sensory-motor function. Corticosterone and phosphate serum levels were measured in the serum and striatum.Results: Net contralateral rotations and asymmetry scores in the fourth, sixth, and eighth weeks after surgery compared with the second week showed a gradual increase in the ۶-OHDA group. The serum levels of corticosterone were ۹۰ ± ۱۳ before surgery, and they declined to ۸۸ ± ۳۶ and ۵۵ ± ۹ ng/L in the second and eighth weeks after surgery, respectively. The serum levels of phosphate were ۶ ± ۰.۲۲ before surgery, and they decreased to ۵.۲ ± ۰.۱۳ and ۵ ± ۰.۱۲ mg/dl in the second and eighth weeks after surgery, respectively. The serum levels of phosphate and corticosterone remained relatively unchanged in the sham and control groups.Conclusion: In conclusion, the progressive death of dopaminergic neurons is accompanied by decreased serum corticosterone and phosphate levels. Thus, the serum level of corticosterone can be used as a biomarker in diagnosing Parkinson’s disease. In contrast, serum phosphate levels were still within the normal range and cannot be used as a biomarker.

نویسندگان

Hashem Haghdoost-Yazdi

Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran

Sepideh Nigjeh

Student Research Committee, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran

Seyed Amir Hadi Hosseini

Student Research Committee, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran

Sahar Sharifi

Student Research Committee, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran

Fatemeh Kaveh

Department of Cellular Therapy, Institute for Cancer Research, Oslo University Hospital, Norway

Hossein Piri

Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Weller J, Budson A. Current understanding of Alzheimer’s disease diagnosis ...
  • Grigoruţă M, Martínez-Martínez A, Dagda RY, Dagda RK. Psychological stress ...
  • Willard AM, Bouchard RS, Gittis AH. Differential degradation of motor ...
  • Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, ...
  • Pagan FL. Improving outcomes through early diagnosis of Parkinson’s disease. ...
  • Calvani R, Picca A, Landi G, Marini F, Biancolillo A, ...
  • Cagney DN, Sul J, Huang RY, Ligon KL, Wen PY, ...
  • Deumens R, Blokland A, Prickaerts J. Modeling Parkinson’s disease in ...
  • Jin F, Wu Q, Lu YF, Gong QH, Shi JS. ...
  • Haghdoost-Yazdi H, Piri H, Faraji A, Fraidouni N, Dargahi T, ...
  • Razaghi R, Piri H, Jafari H, Rastgoo N, Hosseini MA, ...
  • Sofiabadi M, Haghdoost-Yazdi H, Piri H, Esmaeili M. B vitamins ...
  • Minaei A, Sarookhani MR, Haghdoost-Yazdi H, Rajaei F. Hydrogen sulfide ...
  • Magno LAV, Collodetti M, Tenza-Ferrer H, Romano-Silva MA. Cylinder test ...
  • Haghdoost-Yazdi H, Faraji A, Fraidouni N, Movahedi M, Hadibeygi E, ...
  • Subramaniam SR, Chesselet MF. Mitochondrial dysfunction and oxidative stress in ...
  • Herman JP, Seroogy K. Hypothalamic-pituitary-adrenal axis, glucocorticoids, and neurologic disease. ...
  • Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in ...
  • Pacosz J. The Effects of Short-Term Glucocorticoid Exposure on Hippocampal ...
  • Sobesky JL, D’Angelo HM, Weber MD, Anderson ND, Frank MG, ...
  • Vyas S, Rodrigues AJ, Silva JM, Tronche F, Almeida OF, ...
  • Soares NM, Pereira GM, Altmann V, de Almeida RM, Rieder ...
  • Sullivan RM, Gratton A. Relationships between stress-induced increases in medial ...
  • Törnhage CJ, Skogar Ö, Borg A, Larsson B, Robertsson L, ...
  • Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in ...
  • Djamshidian A, O’Sullivan SS, Papadopoulos A, Bassett P, Shaw K, ...
  • Hartmann A, Veldhuis JD, Deuschle M, Standhardt H, Heuser I. ...
  • Mizoguchi K, Ishige A, Takeda S, Aburada M, Tabira T. ...
  • Barnum CJ, Eskow KL, Dupre K, Blandino P Jr, Deak ...
  • Sugama S, Takenouchi T, Kitani H, Fujita M, Hashimoto M. ...
  • Tentillier N, Etzerodt A, Olesen MN, Rizalar FS, Jacobsen J, ...
  • Luan H, Liu LF, Tang Z, Zhang M, Chua KK, ...
  • Håglin L, Bäckman L. Covariation between plasma phosphate and daytime ...
  • Samavarchi Tehrani S, Sarfi M, Yousefi T, Ahmadi Ahangar A, ...
  • Abou-Raya S, Helmii M, Abou-Raya A. Bone and mineral metabolism ...
  • Håglin L. High serum phosphate concentration as the result of ...
  • Meamar R, Maracy M, Chitsaz A, Aghaye-Ghazvini MR, Izadi M, ...
  • نمایش کامل مراجع